DERMAZINC- pyrithione zinc spray 
WynnPharm Inc

----------

DermaZinc Spray/Drop

Pyrithione Zinc 0.25%

Keep Out of Reach of Children.

Anti-dandruff

Seborrheic Dermatitis treatment


Apply to affected areas twice daily or as directed by a doctor.

For relief of the symptoms of seborrheic dermatitis and dandruff.

Warnings
■ For external use only.
■ Ask a doctor before use if you have a condition that covers a large area of the body.

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with
water.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this
product as directed.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Isopropyl Myristate, SD-Alcohol 40-B, Sodium Lauryl Sulfate, Undecylinic Acid

DermaZinc Spray

Inner/Immediate Label

DermaZinc Spray

DERMAZINC 
pyrithione zinc spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:35324-002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC0.25 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
UNDECYLENIC ACID (UNII: K3D86KJ24N)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
ALCOHOL (UNII: 3K9958V90M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:35324-002-041 in 1 BOX08/29/2022
1120 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM03208/29/2022
Labeler - WynnPharm Inc (620885173)
Registrant - WynnPharm Inc (620885173)

Revised: 11/2023
Document Id: 0aefcfef-95e0-3da6-e063-6294a90a948c
Set id: e73010ae-291d-6adf-e053-2a95a90a8aea
Version: 2
Effective Time: 20231124
 
WynnPharm Inc